Short-Term Change in Distance Walked in 6 Min Is an Indicator of Outcome in Patients With Chronic Heart Failure in Clinical Practice

Journal of the American College of Cardiology

Volumn 48, Issue 1, 2006, Pages 99-105

  Passantino, Andrea ^a   Lagioia, Rocco ^a   Mastropasqua, Filippo ^a   Scrutinio, Domenico ^a  

^a IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; METOPROLOL; RAMIPRIL;

AGED; ARTICLE; CLINICAL PRACTICE; DISEASE SEVERITY; EXERCISE; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TIME SERIES ANALYSIS; WALKING;

AGED; CHRONIC DISEASE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT; WALKING;

EID: 33745268839     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.02.061     Document Type: Article

References (29)

1. Fleg J.L., Piña I.L., Balady G.J., et al. Assessment of functional capacity in clinical and research applications. An advisory from the Committees on Exercise, Rehabilitation and Prevention, Council on Clinical Cardiology, American Heart Association. Circulation 102 (2000) 1591-1597
2. Willenheimer R., and Erhardt L.R. Value of 6-min-walk test for assessment of severity and prognosis of heart failure. Lancet 355 (2000) 515-516
3. Mehra M.R., Lavie C.J., and Milani R.V. Predicting prognosis in advanced heart failure. Chest 110 (1996) 310-312
4. ATS statement. guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 (2002) 111-117
5. Abraham W.T., Fisher W.G., Smith A.L., et al., MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
6. Guyatt G.H., Sullivan M.J., Thompson P.J., et al. The 6-minute walk. a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 132 (1985) 919-923
7. Sheffield L.T. Exercise stress testing. In: Braunwald E. (Ed). Heart Disease. A Textbook of Cardiovascular Medicine (1988), Saunders, Philadelphia, PA 223-233
8. Dickstein K., Barvik S., Aarsland T., Snapinn S., and Karlsson J. A comparison of methodologies in detection of anaerobic threshold. Circulation 81 Suppl III (1990) II38-II46
9. Olsson L.G., Swedberg K., Clark A.L., Witte K.K., and Cleland J.G.F. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure. a systematic review. Eur Heart J 26 (2005) 778-793
10. Zugck C., Kriger C., Durr S., et al. Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy?. Eur Heart J 21 (2000) 540-549
11. Gualeni A., D'Aloia A., Gentilini A., Pagani M., Giordano A., and Faggiano P. Effects of maximally tolerated oral therapy on the six-minute walking test in patients with chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 81 (1998) 1370-1372
12. Pinto-Plata V.M., Cote C., Cabral H., Taylor J., and Celli B.R. The 6-min walk distance. change over time and value as a predictor of survival in severe COPD. Eur Resp J 23 (2004) 28-33
13. Refsgaard J. This is a walking test, not a talking test. the six minute walking test in congestive heart failure. Eur Heart J 26 (2005) 749-750
14. Zugck C., Haunstetter A., Krüger C., et al. Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. J Am Coll Cardiol 39 (2002) 1615-1622
15. O'Neill J.O., Young J.B., Pothier C.E., and Lauer M.S. Peak oxygen consumption as a predictor of death in patients with heart failure receiving β-blockers. Circulation 111 (2005) 2313-2318
16. Bittner V., Welner D.H., Yusuf S., et al., SOLVD Investigators. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA 270 (1993) 1702-1707
17. Opasich C., Pinna G.D., Mazza A., et al. Reproducibility of the six-minute walking test in patients with chronic congestive heart failure. practical implications. Am J Cardiol 81 (1998) 1497-1500
18. Cohen-Solal A., Desnos M., Delahaye F., et al. A national survey of heart failure in French hospitals. Eur Heart J 21 (2000) 763-769
19. Bellotti P., Badano P., Acquarone N., et al. Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure. the OSCUR study. Eur Heart J 22 (2001) 596-604
20. Cleland J.G.F., Cohen-Solal A., Aguilar C., et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme). an international survey. Lancet 360 (2002) 1631-1639
21. Di Lenarda A., Scherillo M., Maggioni A.P., et al. Current presentation and management of heart failure in cardiology and internal medicine hospital units. a tale of two worlds-the TEMISTOCLE study. Am Heart J 146 (2003) e12
22. Maggioni A.P., Sinagra G., Opasich C., et al. Treatment of chronic heart failure with β adrenergic blockade beyond controlled clinical trials. the BRING-UP experience. Heart 89 (2003) 299-305
23. Pilote L., Abrahamowicz M., Rodrigues E., Eisenberg M.K., and Rahme E. Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction; a class effect?. Ann Intern Med 141 (2004) 102-112
24. Hutcheon S.D., Gillespie N.D., Crombie I.K., et al. Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction. a randomized double-blind placebo controlled trial. Heart 88 (2002) 373-377
25. Krum H., Sackner-Bernstein J.D., Goldsmith R.L., et al. Double-blind placebo-controlled study of the long-term efficacy of carvedilol in patients with severe heart failure. Circulation 92 (1995) 1499-1506
26. Packer M., Colucci W.S., Sackner-Bernstein J.D., et al. Double-blind, placebo-controlled study of the effects of carvedilol patients with moderate to severe heart failure. The PRECISE trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. Circulation 94 (1996) 2793-2799
27. Cahalin L.P., Mathier M.A., Semigran M.J., Dec W., and DiSalvo T.G. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 110 (1996) 325-332
28. O'Keefe S.T., Lye N., Donnellan C., and Carmichael D.N. Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients. Heart 80 (1998) 377-382
29. Rostagno C., Olivo G., Comeglio M., et al. Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure. comparison with other methods of functional evaluation. Eur J Heart Fail 5 (2003) 247-252